基于哌啶乙酸的γ-分泌酶调节剂直接与早老素-1结合。
Piperidine acetic acid based γ-secretase modulators directly bind to Presenilin-1.
作者信息
Crump Christina J, Fish Benjamin A, Castro Suita V, Chau De-Ming, Gertsik Natalya, Ahn Kwangwook, Stiff Cory, Pozdnyakov Nikolay, Bales Kelly R, Johnson Douglas S, Li Yue-Ming
机构信息
Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
出版信息
ACS Chem Neurosci. 2011 Dec 21;2(12):705-710. doi: 10.1021/cn200098p.
Abstract
Aβ42 is believed to play a causative role in Alzheimer's disease (AD) pathogenesis. γ-Secretase modulators (GSMs) are actively being pursued as potential AD therapeutics because they selectively alter the cleavage site of the amyloid precursor protein (APP) to reduce the formation of Aβ42. However, the binding partner of acid based GSMs was unresolved until now. We have developed clickable photoaffinity probes based on piperidine acetic acid GSM-1 and identified PS1 as the target within the γ-secretase complex. Furthermore, we provide evidence that allosteric interaction of GSMs with PS1 results in a conformational change in the active site of the γ-secretase complex leading to the observed modulation of γ-secretase activity.
摘要
β淀粉样蛋白42（Aβ42）被认为在阿尔茨海默病（AD）发病机制中起致病作用。γ-分泌酶调节剂（GSMs）正作为潜在的AD治疗药物而被积极研究，因为它们能选择性地改变淀粉样前体蛋白（APP）的切割位点，以减少Aβ42的形成。然而，基于酸的GSMs的结合伴侣至今仍未明确。我们基于哌啶乙酸GSM-1开发了可点击的光亲和探针，并确定早老素1（PS1）是γ-分泌酶复合物中的靶点。此外，我们提供的证据表明，GSMs与PS1的变构相互作用导致γ-分泌酶复合物活性位点的构象变化，从而引起所观察到的γ-分泌酶活性调节。
相似文献
1
Piperidine acetic acid based γ-secretase modulators directly bind to Presenilin-1.基于哌啶乙酸的γ-分泌酶调节剂直接与早老素-1结合。
ACS Chem Neurosci. 2011 Dec 21;2(12):705-710. doi: 10.1021/cn200098p.
2
γ-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilin.γ-分泌酶调节剂 (GSM) 光亲和探针揭示了早老素上独特的变构结合位点。
J Biol Chem. 2013 Apr 5;288(14):9710-9720. doi: 10.1074/jbc.M112.398602. Epub 2013 Feb 8.
3
Development and mechanism of γ-secretase modulators for Alzheimer's disease.γ-分泌酶调节剂治疗阿尔茨海默病的研发与作用机制。
Biochemistry. 2013 May 14;52(19):3197-216. doi: 10.1021/bi400377p. Epub 2013 May 2.
4
γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds.一组先进的化合物可在杂合患者状态下克服具有侵袭性的致阿尔茨海默病早老素突变体对γ-分泌酶调节剂的抗性。
Alzheimers Res Ther. 2025 Feb 19;17(1):49. doi: 10.1186/s13195-025-01680-3.
5
Novel γ-secretase enzyme modulators directly target presenilin protein.新型 γ-分泌酶酶调节剂直接靶向早老素蛋白。
J Biol Chem. 2011 Oct 28;286(43):37181-6. doi: 10.1074/jbc.C111.276972. Epub 2011 Sep 6.
6
γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not.γ-分泌酶调节剂对 APP 切割的调节具有选择性，但反向 γ-分泌酶调节剂则没有。
Alzheimers Res Ther. 2020 May 19;12(1):61. doi: 10.1186/s13195-020-00622-5.
7
Complex relationships between substrate sequence and sensitivity to alterations in γ-secretase processivity induced by γ-secretase modulators.底物序列与 γ-分泌酶调节剂诱导的 γ-分泌酶持续性改变的敏感性之间的复杂关系。
Biochemistry. 2014 Apr 1;53(12):1947-57. doi: 10.1021/bi401521t. Epub 2014 Mar 20.
8
Activation of γ-Secretase Trimming Activity by Topological Changes of Transmembrane Domain 1 of Presenilin 1.早老素1跨膜结构域1的拓扑变化激活γ-分泌酶的剪切活性
J Neurosci. 2017 Dec 13;37(50):12272-12280. doi: 10.1523/JNEUROSCI.1628-17.2017. Epub 2017 Nov 8.
9
Beta-amyloid precursor protein mutants respond to gamma-secretase modulators.β-淀粉样前体蛋白突变体对 γ-分泌酶调节剂有反应。
J Biol Chem. 2010 Jun 4;285(23):17798-810. doi: 10.1074/jbc.M110.103283. Epub 2010 Mar 26.
10
Conformational Models of APP Processing by Gamma Secretase Based on Analysis of Pathogenic Mutations.基于对致病性突变的分析的 γ-分泌酶对 APP 加工的构象模型。
Int J Mol Sci. 2021 Dec 18;22(24):13600. doi: 10.3390/ijms222413600.
引用本文的文献
1
γ-secretase targeting in Alzheimer's disease.针对阿尔茨海默病的γ-分泌酶靶向治疗
J Alzheimers Dis Rep. 2025 Jun 23;9:25424823251349529. doi: 10.1177/25424823251349529. eCollection 2025 Jan-Dec.
2
γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds.一组先进的化合物可在杂合患者状态下克服具有侵袭性的致阿尔茨海默病早老素突变体对γ-分泌酶调节剂的抗性。
Alzheimers Res Ther. 2025 Feb 19;17(1):49. doi: 10.1186/s13195-025-01680-3.
3
γ-Secretase in Alzheimer's disease.γ-分泌酶在阿尔茨海默病中的作用。
Exp Mol Med. 2022 Apr;54(4):433-446. doi: 10.1038/s12276-022-00754-8. Epub 2022 Apr 8.
4
Turning the tide on Alzheimer's disease: modulation of γ-secretase.扭转阿尔茨海默病的局势：γ-分泌酶的调节
Cell Biosci. 2022 Jan 4;12(1):2. doi: 10.1186/s13578-021-00738-7.
5
Recent developments of small molecule γ-secretase modulators for Alzheimer's disease.用于阿尔茨海默病的小分子γ-分泌酶调节剂的最新进展
RSC Med Chem. 2020 Aug 27;11(9):1003-1022. doi: 10.1039/d0md00196a. eCollection 2020 Sep 1.
6
The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer's disease.先天免疫蛋白 IFITM3 调节阿尔茨海默病中的 γ-分泌酶。
Nature. 2020 Oct;586(7831):735-740. doi: 10.1038/s41586-020-2681-2. Epub 2020 Sep 2.
7
Targeting Amyloidogenic Processing of APP in Alzheimer's Disease.针对阿尔茨海默病中淀粉样前体蛋白的淀粉样生成加工过程
Front Mol Neurosci. 2020 Aug 4;13:137. doi: 10.3389/fnmol.2020.00137. eCollection 2020.
8
γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase.γ-分泌酶抑制剂和调节剂：γ-分泌酶功能和调节的机制见解。
Semin Cell Dev Biol. 2020 Sep;105:43-53. doi: 10.1016/j.semcdb.2020.03.002. Epub 2020 Apr 2.
9
Extracellular interface between APP and Nicastrin regulates Aβ length and response to γ-secretase modulators.APP 和 Nicastrin 之间的细胞外界面调节 Aβ 长度和对 γ-分泌酶调节剂的反应。
EMBO J. 2019 Jun 17;38(12). doi: 10.15252/embj.2019101494. Epub 2019 May 20.
10
γ-Secretase and its modulators: Twenty years and beyond.γ-分泌酶及其调节剂：二十年及以后。
Neurosci Lett. 2019 May 14;701:162-169. doi: 10.1016/j.neulet.2019.02.011. Epub 2019 Feb 11.
本文引用的文献
1
What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us.三期γ-分泌酶抑制剂试验的中止可能（或可能不）告诉了我们什么。
Ann Neurol. 2011 Feb;69(2):237-9. doi: 10.1002/ana.22365.
2
Novel γ-secretase modulators: a review of patents from 2008 to 2010.新型 γ-分泌酶调节剂：2008 年至 2010 年专利述评。
Expert Opin Ther Pat. 2011 Feb;21(2):205-26. doi: 10.1517/13543776.2011.547479. Epub 2011 Jan 14.
3
γ-Secretase modulators as potential disease modifying anti-Alzheimer's drugs.γ-分泌酶调节剂作为潜在的疾病修饰抗阿尔茨海默病药物。
J Med Chem. 2011 Feb 10;54(3):669-98. doi: 10.1021/jm101168r. Epub 2010 Dec 9.
4
Substrate docking to γ-secretase allows access of γ-secretase modulators to an allosteric site.底物与γ-分泌酶对接可使γ-分泌酶调节剂进入变构位点。
Nat Commun. 2010 Nov 30;1:130. doi: 10.1038/ncomms1129.
5
Activation and intrinsic gamma-secretase activity of presenilin 1.早老素 1 的激活和内在 γ-分泌酶活性。
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21435-40. doi: 10.1073/pnas.1013246107. Epub 2010 Nov 29.
6
Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease.γ-分泌酶的调制可减少阿尔茨海默病转基因小鼠模型中的β-淀粉样蛋白沉积。
Neuron. 2010 Sep 9;67(5):769-80. doi: 10.1016/j.neuron.2010.08.018.
7
Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization.β淀粉样蛋白 42 肽（Abeta42）降低化合物直接与 Abeta 结合，并干扰淀粉样前体蛋白（APP）跨膜二聚化。
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14597-602. doi: 10.1073/pnas.1003026107. Epub 2010 Aug 2.
8
Beta-amyloid precursor protein mutants respond to gamma-secretase modulators.β-淀粉样前体蛋白突变体对 γ-分泌酶调节剂有反应。
J Biol Chem. 2010 Jun 4;285(23):17798-810. doi: 10.1074/jbc.M110.103283. Epub 2010 Mar 26.
9
An APP inhibitory domain containing the Flemish mutation residue modulates gamma-secretase activity for Abeta production.含佛兰芒突变残基的 APP 抑制结构域调节γ-分泌酶活性产生 Aβ。
Nat Struct Mol Biol. 2010 Feb;17(2):151-8. doi: 10.1038/nsmb.1743. Epub 2010 Jan 10.
10
Nonspecificity of binding of gamma-secretase modulators to the amyloid precursor protein.γ-分泌酶调节剂与淀粉样前体蛋白结合的非特异性。
Biochemistry. 2009 Dec 22;48(50):11837-9. doi: 10.1021/bi901839d.
Zotero 插件